Core Insights - The article highlights the upcoming global medical conferences organized by the company, including the first Global Aesthetic Technology Conference on June 12, 2025, and the second Global Medical Technology Conference on July 17, 2025 [1] - Kevin Thornal has been appointed as the President of Global Business and Americas Group at Zimmer Biomet, effective July 1, 2025, where he will oversee commercial operations in the Americas and the strategic execution of various business units [1][4] Company Overview - Zimmer Biomet, founded in 1927 and headquartered in Warsaw, Indiana, focuses on the research, design, production, and sales of orthopedic implants and related surgical products, covering areas such as knee joints, hip joints, spine, trauma, sports medicine, and dental [5][6] - The company operates in over 100 countries with approximately 18,000 employees and ranks third in the global orthopedic field, holding the number one market share in joint products [6] Leadership Insights - Ivan Tornos expressed confidence in Thornal's ability to drive business growth and enhance operational excellence, emphasizing his extensive industry experience [5] - Thornal expressed enthusiasm about returning to the orthopedic field and aims to accelerate the launch of new products to meet clinical needs in musculoskeletal health [5] Product Highlights - The Persona Knee System offers various implant configurations to meet different anatomical and surgical needs, aiming to enhance patient comfort and mobility [6] - The Taperloc Hip System utilizes advanced design and materials to improve the success rate of hip replacement surgeries and long-term patient satisfaction [6] - The Continuum Trabecular Metal Acetabular System is designed for total hip replacement surgeries, featuring highly cross-linked polyethylene materials for superior wear resistance and aging capabilities [6]

报名：首届全球心血管大会 | 奖项报名倒计时 报名：首届全球骨科大会 | 奖项报名倒计时 2025年3月7日， 捷迈邦美Zimmer Biomet （纽约证券交易所代码：ZBH）宣布，其 Persona Revision SoluTion Femur（股骨）膝关节植入物组件 已获得美国食品药品监督管理局（FDA）的510(k)许可。 该组件是 Persona膝关节翻修系统（Persona Revision Knee System） 的一部分，为某些金属敏感的患者提 供了一种替代方案。它采用了一种专有的表面硬化处理技术，旨在提高耐磨性能。该产品为外科医生提供了一 系列解剖组件，包括胫骨和股骨锥，以及多种茎选择，以解决区域固定问题。 合作伙伴征集：2025全球手术机器人大会 报名：首届全球眼科大会 | 暂定议程 # 产品介绍 皮肤金属过敏影响着10%-15%的普通人群，而带有金属植入物的患者中这一比例可能高达25%。当患者接 触到某些常用于金属膝关节植入物的金属时，可能会出现炎症反应、疼痛和植入物松动等问题。 而 Persona Revision SoluTion Femur膝关节植入物 是一款专为膝关节翻修手术 ...